UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000033961
Receipt No. R000038737
Scientific Title Effectiveness and safety of Combination therapy of Ranibizumab and LuseOgliflozin in type 2 diabetes with diabetic Macular Edema, a parallel group comparison with the standard Treatment controlled by Glimepiride, multicenter, randomized, open-label trial. (COMET Trial)
Date of disclosure of the study information 2018/08/30
Last modified on 2019/03/04 18:17:30

No. Disposal Last modified on Item of update
1 Insert 2018/08/30 19:31:50
2 Update 2018/08/30 19:36:54 Key secondary outcomes
3 Update 2018/09/04 09:47:32 Key secondary outcomes
Key secondary outcomes
4 Update 2018/09/04 10:52:15 Key exclusion criteria
Key exclusion criteria
5 Update 2019/03/04 18:17:30 Recruitment status


Contact us.